RxDoctor Payments Data

Neha Jackson

Family · Rockford, ILNPI 1275186397

Payments from drug & device makers

$1,138in general payments, 2019–2025

Across 51 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$519
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$257
  • Johnson & Johnson$229
  • Novartis$39
  • Abbott$24
  • Novo Nordisk$22
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$1,138100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,138 in reported general payments places this provider in the 75th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$40,641
Medicare patients
360
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$153,229
JardianceEmpagliflozin42$61,246
XareltoRivaroxaban53$51,573
Repatha SureclickEvolocumab27$41,792
BrilintaTicagrelor58$38,745
EntrestoSacubitril/Valsartan15$23,206
Metoprolol Succinate231$3,549
Amiodarone Hcl60$1,186
ClopidogrelClopidogrel Bisulfate132$1,134
Potassium Chloride43$1,042
Atorvastatin Calcium110$938
Bumetanide33$809
Carvedilol108$754
Colchicine35$685
Losartan Potassium67$674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$61,24642 claims
Johnson & JohnsonXarelto$229$51,57353 claims
NovartisEntresto$39$23,20615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,941 family providers in Illinois.

Other family in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →